NCT02717845

Brief Summary

Malalignment of the knee joint causes arthritis in later life. Currently there are three surgical ways to treat knee arthritis: total knee replacement, partial knee replacement, and high tibial osteotomy (HTO). The former two very much focus on treating the effect of malalignment, i.e. removing the arthritic joint. However, HTO addresses the cause of the arthritis, namely the joint malalignment. This preserves the patient's joint and it means that a patient will start using the unaffected part of the knee joint more. HTO involves cutting a wedge out the tibia to correct the alignment of that bone with the knee joint, to redistribute load from the affected medial part to lateral part. To keep the tibia in the new position, a medical nail device is attached to keep it in place and allow new bone to regenerate within the wedge. Currently, the market leader for HTO is the TomoFix (by DePuySynthes company) plate and nail device. As the name suggests, TomoFix is fixed at surgery and therefore the change in bone angle cannot be changed afterwards. It does mean that patients can be weight-bearing on the affected leg soon after the HTO procedure. A new CE-marked device is being tested in an interventional trial; it is produced by Ellipse Technologies. This device is an extendable nail and inserted intramedullary; following surgery the nail is tend slowly extended over a period of time until the bone correction is satisfactory. The CISKO imaging study will assess whether there is a difference between the TomoFix and Ellipse system in terms of bone regeneration in the tibial wedge by performing a CT-scan at 3 and 6 months post-operatively. This will be quantified by two independent radiological reports. A secondary objective is to investigate patient satisfaction and also patient pain levels at these time intervals. The degree of bone healing is usually the main factor holding clinicians back when it comes to advising patients on what activities they can return to post-operatively. A difference in bone healing between the two systems may impact on the advice clinicians can give patients regarding recommencing more intense activities such as recreational sports, which ultimately could positively impact patients' health and well-being.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2016

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2016

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

March 15, 2016

Completed
9 days until next milestone

First Posted

Study publicly available on registry

March 24, 2016

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2017

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2017

Completed
Last Updated

April 8, 2016

Status Verified

April 1, 2016

Enrollment Period

10 months

First QC Date

March 15, 2016

Last Update Submit

April 7, 2016

Conditions

Keywords

varus malignmentosteoarthritisknee

Outcome Measures

Primary Outcomes (1)

  • Healing score

    Healing of the osteotomy site after final correction as assessed by two independent radiology reports based on visual assessment of the CT imaging

    3 months

Secondary Outcomes (2)

  • Patient satisfaction score

    6 months

  • Change in KOOS score

    6 months

Study Arms (2)

CT scan Ellipse

EXPERIMENTAL

New medical device for high tibial osteotomy

Device: Ellipse

CT scan Tomofix

ACTIVE COMPARATOR

Established medical device for high tibial osteotomy

Device: Tomofix

Interventions

EllipseDEVICE

diagnostic CT scan imaging

CT scan Ellipse
TomofixDEVICE

diagnostic CT scan imaging

CT scan Tomofix

Eligibility Criteria

Age18 Years - 100 Years
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Provision of written informed consent
  • Males
  • Mental capacity

You may not qualify if:

  • Under age (\< 18 years)
  • Patients lacking mental capacity.
  • Females
  • Current use of nicotine products.
  • Patients who cannot understand English and therefore cannot be consented.
  • Varus deformity greater than 10°
  • Flexion contracture greater than 15°
  • Knee flexion under 90°
  • Medial/lateral tibial subluxation over 1 cm
  • Medial bone loss of over 3 mm
  • Inflammatory arthritis (including use of methotrexate)
  • Arthritis in the lateral compartment
  • Patella baja
  • Weight over 114 kg
  • Severe patella femoral symptoms
  • +4 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cumberland Infirmary

Carlisle, Cumbria, CA2 7HY, United Kingdom

RECRUITING

MeSH Terms

Conditions

Bone MalalignmentOsteoarthritis

Condition Hierarchy (Ancestors)

Bone DiseasesMusculoskeletal DiseasesArthritisJoint DiseasesRheumatic Diseases

Study Officials

  • Chris Hafner, PhD

    NuVasive

    STUDY DIRECTOR

Central Study Contacts

Leon Jonker, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 15, 2016

First Posted

March 24, 2016

Study Start

March 1, 2016

Primary Completion

January 1, 2017

Study Completion

February 1, 2017

Last Updated

April 8, 2016

Record last verified: 2016-04

Data Sharing

IPD Sharing
Will share

Results to be published in peer-reviewed scientific journal

Locations